This clearance is a foundational step in Roche's commitment to enable routine clinical diagnosis with its digital pathology solutions
The primary endpoint in the final analysis was assessed by change in the North Star Ambulatory Assessment at one year after treatment
Vonoprozan is a novel potassium-competitive acid blocker used for the treatment of acid related disorders
Advancing IGC-AD1 Toward Commercialization as a Treatment for Agitation in Alzheimer's
The new 10-year contract will focus on strengthening the partnership for continued transformative innovation for patients
U.S. FDA has informed Moderna that due to administrative constraints, the agency will not complete its review of mRNA-1345 by the PDUFA date of May 12, 2024
The company has posted net profit of Rs.118.82 crores for the Financial Year ended March 31, 2024
Late-breaker Phase 3 STRIDE-10 trial presented as an oral presentation at European Society of Clinical Microbiology and Infectious Diseases
A significant proportion of healthcare professionals still tend to favor branded drugs
Approximately half of all patients with metastatic breast cancer (mBC) express low levels of HER2
Subscribe To Our Newsletter & Stay Updated
